Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. KMITL
  3. Publication
  4. Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome
Loading...
Thumbnail Image

Dimorphism in the T-cell receptor constant region affects T-cell function, phenotype and HIV outcome

Author(s)
Kaewpreedee, Prathanporn
Boonrat, Potchara
Tansiri, Yada
Rowland-Jones, Sarah L.
Hansasuta, Pokrath
Date Issued
July 15, 2019
Type
Article
DOI
10.1097/QAD.0000000000002187
Abstract
Objectives:CD8+ T cells recognize human leukocyte antigen-peptide complex through the T-cell receptor. Although amino acid variation in T-cell receptor variable chains often affects antigen specificity, dimorphism in the beta chain constant region (TRBC1 and TRBC2) is not thought to affect T-cell function. A recent study suggested that adoptive transfer of TRBC1-specific chimeric antigen-receptor-T cells provided an option for T-cell leukemia therapy that preserved T-cell immunity in the TRBC2 subset. This raises an important question as to whether TRBC1+T cells are qualitatively different from TRBC2+T cells.Design:Cross-sectional study.Methods:Sixty-six antiretroviral therapy-naive HIV-infected individuals, including 19 viraemic controllers and 47 noncontrollers, were enrolled. Peripheral blood mononuclear cells were isolated for T-cell functional assays, tetramer analyses, TRBC1 staining and immunophenotyping.Results:Viraemic controllers had a higher proportion of circulating TRBC1+T cells than noncontrollers, raising the possibility that TRBC1+T cells might be associated with HIV control. TRBC1+T cells also showed more functional T-cell responses against both HIV and cytomegalovirus (P < 0.01). The immunophenotypes of TRBC1-bearing T cells were skewed towards naive and central memory phenotypes, whereas the majority of TRBC2-expressing T cells were terminally differentiated. Inverse correlations were observed between %TRBC1+T cells and HIV plasma viral load, which was most pronounced for CD8+ T cells (r =-0.7096, P = 0.00002357).Conclusion:These data suggest that TRBC1+T-cell responses are of better quality than their TRBC2 counterparts, which should be considered in immunotherapeutic strategies for HIV infection. Conversely, depletion of TRBC1+T cells as part of the treatment of TRBC1+ T-cell malignancies may lead to compromised T-cell response quality.
Citation
AIDS, 33(9), 1421-1429, 2019
Subjects

chimeric antigen-rece...

HIV

HIV controllers

immunotherapy

T cells

T-cell receptor β-cha...

vaccine

Metrics
Get Involved!
  • Source Code
  • Documentation
  • Slack Channel
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Need professional help?

The original creators of DSpace-CRIS at 4Science can take your project to the next level, get in touch!

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback